Limba
|
Nastorazepide (Z-360), a cholecystokinin-2/gastrin receptor (CCK2/gastrin receptor)antagonist, combines with gemcitabine prolonged survival and reduces gemcitabine-induced vascular endothelial growth factor (VEGF)expression in a pancreatic carcinoma orthotopic xenograft mouse.
Price | 893,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Nastorazepide (Z-360), a cholecystokinin-2/gastrin receptor (CCK2/gastrin receptor)antagonist, combines with gemcitabine prolonged survival and reduces gemcitabine-induced vascular endothelial growth factor (VEGF)expression in a pancreatic carcinoma orthotopic xenograft mouse. |